1. Ballard, C. A., Forte, K. and Lauerson, N. H. (1978). Plasma Prostaglandin concentration and abortifacient effectiveness of a single insertion of a 3-mg 115(S)methyl-prostaglandin F2α methyl ester vaginal suppository. Contraception, 17, 383–392
2. Bygdeman, M., Green, K., Bergstrom, S., Bundy, G. and Kimball, F. A. (1979). A new Prostaglandin E2 analog for pregnancy termination. Lancet, 1, 1136
3. Bygdeman, M., Martin, J. N., Leader, A., Lundstrom, V., Ramadan, M., Eneroth, P. and Green, K. (1978). Early pregnancy interruption by 15(S) 15 methyl Prostaglandin F2α methyl ester. Obstet. Gynecol., 48, 221–224
4. Csapo, A. I. and Pulkkinen, M. O. (1979). The mechanism of Prostaglandin action on the pregnant human uterus. Prostaglandins, 17, 283–299
5. Csapo, A. I., Herczeg, J., Pulkkinen, M., Kaihola, H. I., Zoltan, I., Csillag, M. and Mocsary, P. (1976). Termination of pregnancy with double Prostaglandin impact. Am. J. Obstet. Gynecol., 135, 1116